Published in Cancer Weekly, May 14th, 2002
Dr. Christos Sotiriou, head of the the microarray facility at the Jules Bordet Institute, Free University of Brussels, Belgium, told the conference that his multinational group had collaborated with Dr. Adrian Harris (Oxford) and the National Cancer Institute (U.S.), to study samples from 99 patients whose clinical outcomes were known. Using a microchip containing fragments of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.